Skip to main content

The use of zanubrutinib in chronic lymphocytic leukemia.

Publication ,  Journal Article
Brander, DM
Published in: Clin Adv Hematol Oncol
December 2022

Duke Scholars

Published In

Clin Adv Hematol Oncol

ISSN

1543-0790

Publication Date

December 2022

Volume

20

Issue

12

Start / End Page

705 / 708

Location

United States

Related Subject Headings

  • Pyrimidines
  • Pyrazoles
  • Piperidines
  • Oncology & Carcinogenesis
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Brander, D. M. (2022). The use of zanubrutinib in chronic lymphocytic leukemia. Clin Adv Hematol Oncol, 20(12), 705–708.
Brander, Danielle M. “The use of zanubrutinib in chronic lymphocytic leukemia.Clin Adv Hematol Oncol 20, no. 12 (December 2022): 705–8.
Brander DM. The use of zanubrutinib in chronic lymphocytic leukemia. Clin Adv Hematol Oncol. 2022 Dec;20(12):705–8.
Brander, Danielle M. “The use of zanubrutinib in chronic lymphocytic leukemia.Clin Adv Hematol Oncol, vol. 20, no. 12, Dec. 2022, pp. 705–08.
Brander DM. The use of zanubrutinib in chronic lymphocytic leukemia. Clin Adv Hematol Oncol. 2022 Dec;20(12):705–708.

Published In

Clin Adv Hematol Oncol

ISSN

1543-0790

Publication Date

December 2022

Volume

20

Issue

12

Start / End Page

705 / 708

Location

United States

Related Subject Headings

  • Pyrimidines
  • Pyrazoles
  • Piperidines
  • Oncology & Carcinogenesis
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Humans